VIDEO + ARTICLE: A blood test to detect Alzheimer’s has moved one step closer to reality. Washington University can measure Alzheimer’s proteins in the blood
126 DRUGS ARE IN ALZHEIMER’S clinical trials. “Every single one represents hope,” according to Closing in on a Cure: Alzheimer’s Clinical Trials Report. Read the
In the lab, fujimycin slowed Alzheimer’s. (Fujimycin is an organ-transplant drug also called FK506 or Tacrolimus.) In past studies, similar drugs, like rapamycin and ciclosporin,
DRUG RESEARCH VIDEO + ARTICLE: This FDA-approved anti-epileptic medication benefits Alzheimer’s in the lab. Learn about the promising research.
HEALTH ARTICLE, 25-POINT CHECKLIST: MEND is UCLA’s 25-step personalized program to reverse memory loss. Nine of 10 participants displayed significant memory improvements. Learn how. Includes
MEDICATION & MOOD: Aggression and agitation are hard challenges in dementia. An important study may offer some simple answers.
OFF-LABEL DRUGS, VIDEO & ARTICLE: The American Heart Association reports the blood pressure drug nilvadipine increases blood flow to the brain’s memory and learning center.
VIDEO + ARTICLE: Scientists are applying an FDA-approved technique, Deep Brain Stimulation, to treat mild Alzheimer’s for 150 patients in Phase-3 clinical trials. Learn more.
In a first-of-its-kind study, FDA-Approved Dantrolene, a muscle relaxant, was delivered through the nose to Alzheimer’s lab animals. It eased their Alzheimer’s by providing therapeutic
VIDEO + ARTICLE: An experimental drug produced by Annovis has received its generic name following successful completion of its Phase II trials. Buntanetap is intended
See why Leqembi is even more effective in males than females, at fighting Alzheimer’s.
Stanford Medicine’s new analysis of a vaccination program found shingles vaccines appear to lower dementia diagnoses by 20% — more than any other known intervention.
The big Alzheimer’s culprits are Amyloid and Tau. Biogen made Leqembi to treat amyloid. Now, they are betting on BIIB080 to treat tau. Learn how this exciting new treatment just got FDA Fast Track Designation.
Three important dementia studies focus on HS-AGING, a type of dementia almost as common as Alzheimer’s in the 85+ group. Yet few people have heard of it. Why? What makes it different?
An intriguing study of 120 grandmothers might surprise you. Doctors know socially engaged people have better cognition and less dementia. But can a person get too much of a good thing? What’s the right balance?
Enjoy this great duet between a musician with dementia and his son. A triumph of spirit over Alzheimer’s! Sing-a-long if you like!
It looks like a sneeze cannot give anyone Alzheimer’s. While Alzheimer’s abnormal disease proteins do spread from cell-to-cell, they are not “infectious”. Check out the facts.
No spam, only news and updates.
